| Title: |
A Post-Market Economic Evaluation of Bortezomib, Lenalidomide and Dexamethasone Versus Pre-funding Standard of Care for Newly Diagnosed Multiple Myeloma Using Registry Data |
| Authors: |
Irving, AdamAff1, Aff2, IDs40273025015544_cor1; Petrie, DennisAff1; Harris, AnthonyAff1; Fanning, LauraAff1, Aff2; Wood, Erica M.Aff2; Moore, ElizabethAff2; Wellard, CameronAff2; Waters, NeilAff2; Augustson, BradleyAff3; Cook, GordonAff4; Gay, FrancescaAff5; McCaughan, GeorgiaAff6, Aff7; Mollee, PeterAff8; Spencer, AndrewAff9; McQuilten, Zoe K.Aff2 |
| Source: |
PharmacoEconomics. 44(1):83-95 |
| Database: |
Springer Nature Journals |